Details of the Drug Reposition

General Information of This Drug (ID: DM7K4YR)

Drug Name
MIS-416   DM7K4YR
Synonyms Microparticle adjuvant (anthrax), Virionyx; Microparticle adjuvant (iv, autoimmune disease/cancer/anthrax), Innate Therapeutics

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Autoimmune diabetes DISW6UF1 5A10 Phase 2 [1]
------------------------------------------------------------------------------------
1 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Bacillus anthracis infection DIS6ZHWU 1G40 Investigative [1]
------------------------------------------------------------------------------------

References

1 Targeting Innate Receptors with MIS416 Reshapes Th Responses and Suppresses CNS Disease in a Mouse Model of Multiple Sclerosis. PLoS ONE 9(1): e87712. January 31, 2014.